No profile data available.
Nexgel, Inc. (NXGL) is a non-energy raw materials company in the taste and scent chemical compounds industry, based in Langhorne, United States, with about 19 full-time employees.
It reported revenue of $11.42 million for fiscal year 2025, up 31.5% from fiscal year 2024, and net income of -$3.00 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $3.69 million, up 27.8% from a year before. Its largest business segment, Nexgel, brought in 75% of segment revenue in fiscal year 2025. Its market capitalization was $97,622 as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs.
Nexgel reported $11.42 million in revenue for fiscal year 2025, up 31.5% from $8.69 million in fiscal year 2024. In Q2 2026 revenue was $3.69 million.
Nexgel, with $8.61 million or 75% of segment revenue in fiscal year 2025. Next: CGN JV (25%).
$97,622 as of October 9, 2026.
Listed companies of a similar size in the same industry (taste and scent chemical compounds) include EvoNext Holdings SA (ELVAF), InMed Pharmaceuticals Inc. (INM), Sirona Biochem Corp. (SRBCF), Bolt Projects Holdings, Inc. (BSLK).